DR. MED. HENRICH
PROVEGAN STIFTUNG
www.ProVegan.info

Studie: Fluvoxamine zeigt bei der Behandlung von COVID-19 eine gute Wirkung

Referenz: Reis, G. et al. (2021) "Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial", The Lancet Global Health. doi: 10.1016/s2214-109x(21)00448-4. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00448-4/fulltext

 

Studie im Video erklärt: https://www.youtube.com/watch?v=gPqoFFJAaDY